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Functional outcomesCervical spinal cord injury (SCI) can result in devastating functional deﬁcits that involve the respiratory and hand
function. The mammalian spinal cord has limited ability to regenerate and restore meaningful functional recov-
ery following SCI. Riluzole, 2-amino-6-triﬂuoromethoxybenzothiazole, an anti-glutamatergic drug has been
shown to reduce excitotoxicity and confer neuroprotection at the site of injury following experimental SCI.
Based on promising preclinical studies, riluzole is currently under Phase III clinical trial for the treatment of SCI
(ClinicalTrials.gov: NCT01597518). Riluzole's anti-glutamatergic role has the potential to regulate neuronal func-
tion and provide neuroprotection and inﬂuence glutamatergic connections distal to the initial injury leading to
enhanced functional recovery following SCI. In order to investigate this novel role of riluzole we used a high cer-
vical hemisectionmodel of SCI, which interrupts all descending input to motoneurons innervating the ipsilateral
forelimb and diaphragm muscles. Following C2 spinal cord hemisection, animals were placed into one of two
groups: one group received riluzole (8 mg/kg) 1 h after injury and every 12 h thereafter for 7 days at 6 mg/kg,
while the second group of injured rats received vehicle solution for the same duration of time. A third group of
sham injured rats underwent a C2 laminectomy without hemisection and served as uninjured control rats. In-
terestingly, this study reports a signiﬁcant loss of motoneurons within the cervical spinal cord caudal to C2
hemisection injury. Disruption of descending input led to a decrease in glutamatergic synapses andmotoneurons
caudal to the injury while riluzole treatment signiﬁcantly limited this decline. Functionally, Hoffmann reﬂex re-
cordings revealed an increase in the excitability of the remaining ipsilateral cervical motoneurons and signiﬁcant
improvements in skilled and unskilled forelimb function and respiratory motor function in the riluzole-treated
animals. In conclusion, using a C2 hemisection injury model, this study provides novel evidence of motoneuron
loss caudal to the injury and supports riluzole's capacity to promote neuronal preservation and function of neural
network caudal to the SCI resulting in early and sustained functional improvements.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
High cervical spinal cord injury (SCI) disrupts supraspinal connections
to lower motoneurons and spinal circuitry leading to signiﬁcant loss of
sensory, motor and respiratory function. Majority of injuries to the spinal
cord occur at the cervical level and are incomplete, with spared axonal
connections to cervical respiratory and somatic motoneurons from
supraspinal centers. The central nervous system shows limited capacity
to regenerate following partial injuries (Kerschensteiner et al., 2004;
Raineteau et al., 2002), however, spontaneous locomotor and respiratory
recovery can occur to a limited extent associated with various forms of
anatomical and functional plasticity within the caudal cervical regionToronto Western Hospital, 399
anada.
gs).
. This is an open access article under(Lane et al., 2008). This spontaneous plasticity-mediated recovery in itself
is not sufﬁcient and leads to limited functional recovery and, as such, ef-
fective therapeutic strategies are needed to promote sensory, motor and
autonomic functional recovery followingSCI (Dougherty et al., 2012). Fur-
ther, many strategies to strengthen connectivity have presumed thatmo-
toneurons within the cervical spinal cord remain intact after high cervical
hemisection injury. The fate of motoneurons within the cervical neural
circuitry distal to a left C2 hemisection injury is not known. Synergistic
neural tissue protection and promotion of structural and functional plas-
ticity of the spared circuitry caudal to the injury is a promising option for
restoring meaningful functional recovery.
Loss of descending excitatory input tomotoneurons caudal to the in-
jury site leads to the paralysis of muscles innervated by these unexcit-
able motoneurons. Based on promising preclinical data, riluzole, the
only FDA approved drug for ALS and a glutamatergic modulator, is
currently in Phase III clinical trial for the treatment of SCI (Grossmanthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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riluzole has been demonstrated to increase tissue preservation at the
site of injury leading to locomotor functional recovery (Wu et al.,
2013; Schwartz and Fehlings, 2001). In the CNS, riluzole inhibits gluta-
mate release and promotes reuptake by astrocytes resulting in improved
glutamatergic regulation (Anon., 2003; Frizzo et al., 2004; Heurteaux
et al., 1994; Kim et al., 2007; Kniest et al., 2001; Pereira et al., 2014). In ad-
dition, riluzole also has the ability to modulate synaptic activation of the
ionotropic glutamate receptors N-methyl-D-aspartate (NMDA) and 2-
amino-3-(3-hydroxy-5-methyl-isoxazol-4-yl) propanoic acid (AMPA).
Both NMDA and AMPA receptor modulation of neurons play a key role
in synaptic plasticity (Malinow and Malenka, 2002; Mantilla et al.,
2012). At the acute stage, in the injured spinal cord, riluzole's role in de-
creasing intraspinal glutamate levels and excitotoxicity to promote tissue
preservation has been demonstrated by our laboratory and others. Tissue
preservation can be a signiﬁcant mediator of functional recovery follow-
ing SCI as it has been demonstrated that even a small amount of tissue
preservation can lead to substantial functional recovery (Fehlings and
Tator, 1995). However, riluzole's ability to modulate synaptic glutamate
receptors to enhance synaptic strength, amplify motoneuron excitability
and protect motoneurons caudal to the injury site has not been explored
following SCI. Further examination and understanding of these mecha-
nisms is important to optimize its use in the clinic.
Here,we interrogated the hypothesis that high cervical SCImediated
decrease in synaptic input onto caudal motoneurons leads to a decrease
in their excitability and survival. Most importantly, for the ﬁrst time this
study reveals that a sharp hemisection injury to the cervical spinal cord
at C2 leads to signiﬁcant loss of motoneurons within a speciﬁed region
of the cervical enlargement. Also, this study demonstrates that acute
and subacute administration of riluzole following C2 hemisection par-
tially restores respiratory related diaphragmatic function and promotes
forelimbmotor recovery by preventing this loss ofmotoneurons and en-
hancing their glutamate receptor-mediated connectivity.
2. Materials and methods
All experimental procedures were performed on male Wistar rats
(2–3 months; 300–325 g; Jackson laboratories). Animal care and han-
dling were conducted with the approval of the animal care committee
of the University Health Network in accordance with the policies
outlined in the guide on the care and use of experimental animals pre-
pared by the Canadian Council of Animal Care. Rats were housed indi-
vidually with free access to food and water.
2.1. Experimental design
40 rats were subjected to complete left hemisection of the spinal
cord from the midline below the C2 dorsal roots. Injured animals were
placed into one of two groups: one group of animals received intraper-
itoneal (IP) administration of riluzole (Sigma, R116) (8mg/kg) 1 h post-
C2 hemisection injury and every 12 h thereafter for 7 days at 6 mg/kg
(n = 18). A second group of injured rats served as vehicle treated con-
trols and were administered vehicle solution 1 h post-injury and twice
daily (IP) for the sameduration of time (n=17). Riluzolewas dissolved
in 30% (w/v) of solubilizer 2-hydroxypropyl-β-cyclodextrin (HBC,
Sigma, H-107). A third group of sham injured rats underwent a C2
laminectomy without hemisection and served as uninjured control
rats (n = 5). An investigator blinded to the experimental groups pre-
pared all experimental drugs and the dose of riluzole used in this
study was based on our previous work on the pharmacodynamic and
kinetic properties of riluzole (Wu et al., 2013). Spontaneous and
riluzole-induced changes in skilled and unskilled forelimb function
were monitored for 6 weeks post-injury. Terminal electrophysiological
experiments were performed at 2 and 6 weeks to evaluate respiratory
functional recovery and motoneuron excitability, respectively (Fig. 1).2.2. Spinal cord injury: C2 hemisection
35 rats were anesthetized with 2% isoﬂurane in oxygen (1 l/min)
and placed in a stereotaxic frame on a heating pad at 37 °C. Under asep-
tic conditions, following a midline dorsal incision the superﬁcial mus-
cles were retracted to expose the dorsal spinal cord. Following a C2
laminectomy and durotomy, the left side of the spinal cord was
hemisected from the midline extending to the lateral spinal cord using
microscissors (Kajana and Goshgarian, 2008). The hemisection was
just caudal to the dorsal roots of the second cervical segment and the
dorsal roots were not injured. A surgical probe was used to ensure ana-
tomical completeness of the hemisection by scraping theﬂoor andwalls
of the vertebral canal adjacent to the lesion. Following surgery, all ani-
mals received analgesic (Buprenorphine 0.5 mg/kg; twice daily for
48 h) and 10.0 ml of saline subcutaneously. Animals were placed
under heat lamps in individual cages to recover during post-operative
recovery period. The rats were maintained in a 12-h light/dark cycle in
a temperature-controlled room at 27 °C for the duration of the experi-
ment. Spinal tissue at the site of injury was stained with hematoxylin
and eosin to conﬁrm the completeness of the hemisection injury. In
order to verify the loss of cervicalmotoneurons, a left C2hemisection in-
jury or sham surgerywas performed in a groupof ChAT-eGFP transgenic
mice that express the green ﬂuorescence protein (GFP) under the con-
trol of choline acetyltransferase promotor (Jackson Laboratory B6.Cg-
Tg(RP23-268L19-EGFP)2Mik/J). This transgenic mouse line allows for
ﬂuorescent visualization of cholinergicmotoneurons and cholinergic in-
terneurons in the neonate aswell as in adult mice. 6 weeks after the left
C2 hemisection or sham surgery, the spinal cord from C2 to T3 was ex-
amined for expression of eGFP expressing neurons in the ventral horn.
2.3. Functional assessments
Investigators blinded to treatment groups carried out all of the neu-
robehavioral assessments and analysis from day one until 6weeks post-
injury.
2.4. Forelimb grip strength assessment
Ipsilateral and contralateral forelimb grip strengthswere individual-
ly evaluated using a grip strength meter (Grip Strength System, DFM-
1d; San Diego Instruments, San Diego, CA) every other day during the
ﬁrst 2weeks (at days 1, 3, 5, 7, 9, 11, 13, and 15) and once perweek dur-
ing weeks 3, 4, 5 and 6. The animals were held parallel to a series of
metal grip bars and allowed to grasp the bar individually with the ipsi-
lateral alone and contralateral forelimb. After grasping the bar, animals
were pulled away parallel to the degree they were held at until they re-
leased the bar and their grip forcewasmeasured. Ipsilateral and contra-
lateral grip strengths were tested ﬁve times per session. The average
ipsilateral and contralateral grip strength in gramsof forcewas recorded
for ipsilateral and contralateral forelimbs of each animal at each
assessment.
2.5. Paw placement test
Spontaneous forelimb usagewas evaluated during explorative behav-
ior in a transparent cylinder of 20 cm indiameter and30 cm inheight at 2,
4 and 6 weeks after injury. A mirror placed behind the cylinder was used
to observe forelimb movements from all angles. The use of the cylinder
encouraged vertical exploration using the forelimb and the behavior
was recorded and analyzed ofﬂine in slow motion. The number of times
the animal reached up and placed its ipsilateral forelimb, contralateral
forelimb or both forelimbs was recorded. Ipsilateral and contralateral
forelimb placements were represented as the percentage of the
total number of paw placements [% ipsilateral/contralateral forelimb
placement = (ipsilateral/contralateral forelimb placement + both
forelimb placement) / total forelimb placements × 100].
Fig. 1. Schematic view of the forelimb and respiratory circuitry in the cervical spinal cord and the experimental design.
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To further elucidate the forelimb and forepaw function across the
experimental groups, gait analysis using the CatWalk gait analysis sys-
tem was performed at 2 and 4 weeks post-injury for sham operated
(n = 4), vehicle treated (n = 7) and riluzole treated (n = 7) animals
as has been previously described (Karadimas et al., 2013; Iwasaki
et al., 2014). In this study, following labeling of the digital prints collect-
ed via the CatWalk the following parameters were examined: a) paw
print width (horizontal distance of the entire paw), b) paw print length
(vertical distance of the entire paw), c) stride length, and d) swing
speed for both ipsilateral and contralateral forelimbs.
2.7. Motoneuron excitability
Seven weeks post-C2 hemisection, terminal electrophysiological ex-
periments were performed to assess cervical motoneuron excitability.
Riluzole-treated (n = 6) and vehicle-treated (n = 6) injured rats as
well a groupof sham injured (n=4) ratswere subjected to frequency de-
pendent depression of the H-reﬂex in ipsilateral and contralateral fore-
limbs. H-reﬂex recordings from both forelimbs were performed under
isoﬂurane anesthesia. The ulnar nerves in the forelimbs were stimulated
with bipolar needle electrodes and EMG activity was recorded from
interosseusmuscles of the forelimbs. H-responsewas stimulatedwith in-
creasing intensities to determine the threshold to elicit the H-response
and themaximumM- andH-wave responses. Subsequently, the intensity
that elicited maximal H-response was used to deliver pulses at 0.2, 1, 2
and 5 Hz. The EMG activity was ampliﬁed and ﬁltered between 10 and
3000 Hz. The maximal M and H wave amplitudes were measured and
expressed as Hmax/Mmax ratio. Hmax/Mmax ratio, which represents
motor neuron excitability, was calculated for each stimulation frequency.
2.8. Respiratory motoneuron output
Diaphragmatic EMG recording from the ipsilateral hemidiaphragm
was used to determine the ability of riluzole to increase the efﬁcacy ofspared spinal connections to the cervical respiratory motoneurons in a
subset of the injured animals. Two weeks post C2 hemisection injury,
under isoﬂurane anesthesia a laparotomy was performed at the base
of the rib cage to access the abdominal surface of the diaphragm. Bipolar
silver electrodes were inserted bilaterally into the diaphragm and EMG
muscle activity was differentially ampliﬁed at 10,000× and ﬁltered
(0.1–3 kHz) and acquired using a Cambridge Electronic Data acquisition
system (CED1401) and Spike 2 software (Kajana and Goshgarian, 2008;
Alilain and Goshgarian, 2008). To ensure standardized recording con-
ditions, animals from all experimental groups were maintained on a
heating pad. Qualitative analysis of the ipsilateral hemidiaphragmatic
EMG recording was used to determine the number of animals that
displayed respiratory related EMG activity on the ipsilateral
hemidiaphragm. Subsequently, the recovered hemidiaphragmatic
activity was rectiﬁed and integrated using the CED spike 2 data anal-
ysis software and 60 s of respiratory related activity was quantiﬁed.
Mean integrated inspiratory burst area and amplitude of the ipsilat-
eral hemidiaphragm was expressed as a percentage of the contralat-
eral hemidiaphragm.
2.9. Tissue processing
Seven weeks post-surgery, under deep isoﬂurane anesthesia
animals were transcardially perfused with 60 ml of ice-cold 0.1 M
phosphate-buffered solution (PBS) followed by 4% paraformaldehyde
in PBS (Sigma-Aldrich, St. Louis, MO, USA). Subsequently the cervical
spinal cords were post-ﬁxed overnight in 10% sucrose in PFA at 4 °C
and then cryoprotected in 30% sucrose in PBS at 4 °C for 24 h. A two cen-
timeter spinal cord section from C1 to C7 was embedded in optical cut-
ting temperature (OCT) matrix and transversely sectioned at 40 μm
thickness with freezing microtome from 3000 μm rostral to 15,000 μm
caudal to the hemisection epicenter and stored at−80 °C.
2.10. Immunohistochemistry
Neuroprotection caudal to high cervical hemisection was assessed
using ChAT positive ventral horn motoneurons. Sections were washed
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5%nonfatmilk, 1% BSA, and 0.3% Triton X-100 for 1 h. Sectionswere ﬁrst
incubated overnight at 4 °C in primarymouse ChAT antibody (Millipore;
1:100) and subsequently washed in PBS and incubated with secondary
antibody in blocking solution with 0.3% Triton-X. A Biotin–Avidin com-
plex (ABC kit, Sigma-Aldrich) was used to conjugate and reacted with
0.05% 3,3″-diaminobenzidine hydrogen peroxide for 3–15min for visu-
alization. Finally, the sectionswere washed in PBS, dehydrated and cov-
ered with mounting medium. Motoneurons within the ipsilateral and
contralateral ventral horns were quantiﬁed using unbiased stereology.
2.11. Immunoﬂuorescence
Overall changes in synapses in the ventral horn were examined
using antibodies directed at synaptophysin (1:50; Millipore). Speciﬁc
alterations in glutamate receptor expression were detected with the
NMDA receptor subunit (NR2A, 1:100; Millipore) and AMPA receptor
subunit (GLUR1, 1:100). Motoneurons were probed by overnight incu-
bation at 4 °C with mouse anti-choline acetyltransferase (ChAT, 1:100;
Millipore) in blocking solution. Sections were incubated overnight
with primary antibodies. The slides were then washed three times
with PBS and incubated with ﬂuorescent Alexa 488, 588 or 647 second-
ary antibodies (1:500, Invitrogen). The slides were ﬁnally coverslipped
with Mowiol which contained the ﬂuorescent anti-nuclear stain 4′,6-
diaminidino-2-phenylindone (DAPI).
2.12. Stereological quantiﬁcation
Ventral horn motoneuron counts were completed using unbiased
stereological quantiﬁcation. For this quantiﬁcation, a total of 10 mm of
tissue between C3 and C8was sampled at every tenth section beginning
at a random starting point chosen by the random number generator onFig. 2. Synaptophysin immunostaining in cervical spinal cord ventral horn 6 weeks after left C2
injured animals treated with riluzole were stained with the nuclear marker DAPI (blue), ChAT (
in a sham animal associated with ventral hornmotoneurons labeled with ChAT. The bottom tw
lesionedmotoneurons treatedwith riluzole compared to vehicle treated controls. Quantiﬁcatiothe StereoInvestigator software. The optical fractionator sampling probe
of the softwarewas used forworkﬂow creation and sampling design. On
each sectionquantiﬁed, the ipsilateral and contralateral dorsal andventral
hornswere separately traced. For each tracing, a systematic random set of
samples measuring 200 × 200 mm was generated. The optical
fractionator's unbiased counting frame for all counts was
100 × 150 mm. The thicknesses of the sections were measured using
the software and the average thicknesswas reduced to 80% of the original
thickness. Using the optical fractionator's workﬂow probe, immuno-
stained cells that fell within or on inclusion lines of the sampling frame
were considered neurons. The settings used to complete stereological
counts were: 1/section sampling factor = 15, 1/area sampling factor =
2.78, tissue sampling factor (TSF) = 0.78, guard zone = 6 μm.
2.13. Statistical analysis
All statistical analysis was computed using SigmaStat software.
Groups were compared using Student's t-test, one-way ANOVA tests,
and two-way repeated-measures ANOVA tests followed by post-hoc
analysis using Bonferroni's test as indicated. Data presented in the
results are mean +/− SEM unless otherwise indicated. Values of
p b 0.05 were considered to be signiﬁcant.
3. Results
3.1. Riluzole restores synaptic input onto cervical motoneurons following
C2 hemisection injury
In uninjured sham animals, synaptophysin expression was found to
be distributed in the cervical spinal gray matter as well as through the
white matter (Fig. 2). Synaptophysin immunoreactivity was intensely
aggregated on the soma and dendrites within lamina 1×. The effectshemisection and riluzole treatment. Cervical spinal cord sections from sham, injured and
red) and synaptophysin (green). Top panel demonstrates synaptophysin immunolabeling
o panels show signiﬁcantly more preservation of synaptophysin labeling on the surface of
n of immunolabeling revealed no signiﬁcant difference on the contralateral uninjured side.
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vical ventral horn synaptophysin immunoﬂuorescence levels were sig-
niﬁcant (one way ANOVA, p b 0.001). Six weeks after left C2 spinal
cord hemisection, synaptophysin expression level on the left cervical
spinal cord was 10.31 + 1.11 and 13.46 + 1.05 in vehicle and riluzole
treated groups, respectively. Synaptophysin expression was signiﬁcant-
ly lower in both injured groups compared to sham injured animals (p b
0.001). However, synaptophysin expression levels on the contralateral
side of the injured cervical spinal cord were not altered in injured
groups compared to sham animals. Riluzole treated group had a sig-
niﬁcantly elevated levels of synaptophysin on the injured side of the
cervical spinal cord compared to injured animals treated with vehicle.
This elevated level of synaptophysin expression was found on ChATFig. 3.At 6weeks after left C2 hemisection injury, immunostaining demonstrates that expressio
associatedwith ventral hornmotoneurons were signiﬁcantly enhanced in the riluzole treated a
the injury GluR1 subunit was upregulated bilaterally in the riluzole treated animals (p b 0.05).positive ventral horn motoneurons with dendritic projections associat-
ed with synaptophysin positive terminals.
3.2. Riluzole treatment was associated with increased NR2A and GLUR1
expression ipsilateral to the injury
Alterations in speciﬁc AMPA and NMDA receptor subunits were
assessed. Speciﬁcally, alterations in the NR2A subunit of the NMDA
receptor were examined to demonstrate lasting changes in synaptic ef-
ﬁcacy. NR2A and GLUR1 immune reactivity was seen associated with
neurons in the anterior horn of cervical spinal cord caudal to the injury.
In the caudal cervical region, ipsilateral to the injury, NR2A levels were
signiﬁcantly decreased compared to the corresponding region in then of the NR2A subunit of the NMDA receptor and the GLUR1 subunit of the AMPA receptors
nimals compared to controls. While, NR2A increasewas only seen on the side ipsilateral to
64 K. Satkunendrarajah et al. / Experimental Neurology 276 (2016) 59–71sham group (p b 0.01) (Fig. 3). Treatment with riluzole after injury
resulted in signiﬁcantly attenuating this decrease, with the treated
group showing no signiﬁcant decrease compared to the uninjured
group. Comparison of NR2A levels between the injured groups showed
a signiﬁcantly greater level in the riluzole treated group compared to
the vehicle treated group (p b 0.05).
Secondly, this part of the study addressed the question of whether
synapses containing NR2A receptors also contained the Ca2+ imperme-
able AMPA receptors composed of GLUR1 subunits. We found that
NR2A immunoreactive punta on vernal horn neurons were colocalized
with GLUR1 immunoreactivity. Colocalization of these subunits was ex-
amined in quadruple labeled sections (Fig. 3). There was extensive
colocalization of NR2A, GLUR1 and NeuN. As such, the immunoﬂuores-
cence level of GLUR1 followed that of NR2A in the three different exper-
imental groups examined. That is to say, the signiﬁcant decrease in
GLUR1 immunoreactivity following injury was returned to control
levels as a result of riluzole treatment (Fig. 3).
3.3. Riluzole increases ipsilateral motoneuronal excitability following high
cervical hemisection
In order to evaluate the excitatory state of the cervical spinal circuitry
innervating the forelimb that could underlie themechanism of functional
recovery, an analysis of the H-response was carried out at various stimu-
lation frequencies. TheH- andM-waveswere obtained by stimulating theFig. 4. Riluzole treatment results in recovery of ventral horn excitability (A) Representative
(B) Results shown are the rate-dependent depression of H/M tested at 0.2, 1, 5, and 10 Hz. At
between control and riluzole treated animals. (C) At 6 weeks after C2 hemisection injury, ipsil
that of riluzole and control treated animals (p b 0.05 at all frequencies).radial nerve and recording muscle response from the extensor carpi
radialis muscle. Direct M-wave, which is the orthodromically activated
muscle response, and the recurring H-wave were consistently repro-
ducible with similar morphology in sham and both of the injured
groups (Fig. 4). The H-wave represents the persistent output from
antidromically-stimulated motor neurons (Milanov, 1992; Fisher,
1992). In particular, H-wave amplitude has been shown to be ameasure
of spinal motoneuron excitability. There were no differences in H- and
M-wave latency between the three groups indicating a lack of peripher-
al nerve involvement following injury or treatment (Fig. 4A). The
stimulus intensity required to elicit M-wavewasmuch lower compared
to the threshold intensity required to evoke the H-wave (data not
shown). Maximal M-wave was also achieved at a lower stimulus inten-
sity compared to that required for themaximal H-response. The ratio of
maximal H-wave to maximal M-wave was compared at stimulation in-
tensity that evokedmaximal H-wavewithout depressingM-wave at in-
creasing stimulation frequencies (Fig. 4). Increasing the stimulation
frequency from 0.2 to 10 Hz did not alter the amplitude of the direct
muscle response but had a signiﬁcant depressive effect on the H-
response from both the ipsilateral and contralateral neuronal circuitry.
This frequency dependent depression was seen bilaterally in all three
experimental groups. C2 hemisection injury resulted in a signiﬁcant de-
crease in the excitability of ipsilateral cervical spinal circuitry at 0.2 Hz,
1 Hz, 5 Hz and 10 Hz stimulation frequencies (p b 0.05). Riluzole-
treatment following this high cervical SCI led to the restoration ofwaveforms of Hmax/Mmax waves in injured, riluzole treated, and non-injured animals.
6 weeks after C2 hemilesion injury there are no differences in contralateral forelimb H/M
aterally, vehicle treated animals show reduced H/M at all frequencies tested compared to
Fig. 5.Measure of Choline Acetyltransferase (ChAT) positive cells within 10mm long cervical spinal cord containing presumptive PMNs and forelimb speciﬁcmotoneurons using unbiased
stereology. Motoneuron countingwas signiﬁcantly reduced in the injured group compared to sham animals bilaterally. Riluzole treated animals had signiﬁcantlymore cervical motoneu-
rons bilaterally compared to vehicle treated animals (p b 0.05).
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alone or injury in combination with riluzole administration did not af-
fect the Hmax/Mmax ratios obtained from the contralateral forelimb.
3.4. Riluzole attenuates motoneuronal loss following C2 hemisection injury
Loss of excitatory supraspinal input combinedwith a decrease in spi-
nal inhibitory input can lead to changes in the number of motoneurons
caudal to the injury. Examination of the ventral horn motoneurons
within an 8 mm cervical spinal segment containing the forelimb and
respiratory circuitry revealed a signiﬁcant reduction in the number of
ChAT-positive motoneurons ipsilateral (p b 0.001) and contralateral
(p b 0.05) to the injury compared to same spinal areas in the sham
injured spinal cord (Fig. 5). The reduction was signiﬁcantly more pro-
nounced on the side ipsilateral to the injury compared to the contralat-
eral side.With the initiation of riluzole treatment at 1 h following injury,Fig. 6. Loss of cervical ventral hornmotoneurons following left C2 hemisection. Photomicrograp
after left C2 hemisection injury. This clearly demonstrates and validates our reported loss of vethe injury-induced reduction in the number of motoneurons was stark-
ly dampened on both ipsilateral and contralateral sides of the injury.
The riluzole treatment-induced effect was seen on both the left and
right sides of the spinal cord with the riluzole-treated group having sig-
niﬁcantly more ventral horn motoneurons compared to the vehicle-
treated group. To further validate the signiﬁcant loss of motoneurons
within the cervical enlargement caudal to the left C2 hemisection injury,
a left C2 hemisectionwas carried out in ChAT-eGFP transgenic mice and
examined the spinal cord fromC1 to T3 for expression of eGFP in cholin-
ergic neurons (Fig. 6). Initial, confocal imaging of the cervical spinal cord
sections from left C2 hemisected ChAT-eGFP mice demonstrated a de-
creased eGFP positive neurons in the ipsilateral anterior horn of the
gray matter compared to the contralateral side. To fully appreciate the
region and extent of motoneuron loss, we performed 3D reconstruction
of the spinal cord tissue from ChAT-eGFP mice after left C2 hemisection
using the Stereoinvestigator software. This detailed work clearly andh shows a representative cervical spinal cord section at C5 froma ChAT-eGFPmice 6weeks
ntral horn motoneurons caudal and ipsilateral to a left C2 hemisection injury.
Fig. 8. Riluzole promotes early and sustained plasticity resulting in ipsilateral and contra-
lateral forelimb motor recovery. Immediately after cervical (C2) spinal cord hemisection,
ipsilateral grip strength was signiﬁcantly decreased. Injured rats displayed spontaneous
recovery of grip strength ability that plateaued at 15dayspost-injury. Both riluzole and ve-
hicle treated animals displayed recovery of ipsilateral grip strength over the tested period.
Riluzole treated animals displayed signiﬁcantly greater recovery of ipsilateral grip
strength compared to vehicle treated animals as early as 5 days post-injury. The
riluzole-mediated recovery was sustained (two-way ANOVA, p b 0.01 for all time
points). Contralateral forelimb grip strength was also signiﬁcantly decreased after injury.
Riluzole promoted delayed recovery of contralateral grip strength at day 23 post-injury
(2-way ANOVA, p b 0.001 at all time points).
Fig. 7. ChAT positive neurons were mapped using Neurolucida to create a 3D reconstruc-
tion of the spinal cord from the site of injury at C2 rostrally to T3 caudally.
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speciﬁc area of the cervical enlargement where majority of the respi-
ratory and forelimb motoneurons are located (Fig. 7).
3.5. Riluzole promotes recovery of forelimb and forepaw function following
high cervical hemisection injury
Riluzole treatment following high cervical spinal cord hemisection
injury elicited early recovery of ipsilateral forelimb grip strength while
the contralateral forelimb recovery emerged much later. High cervical
hemisection injury resulted in signiﬁcant deﬁcits in ipsilateral forelimb
grip strength, evident as early as one day post-injury (Fig. 8a). Contra-
lateral forelimb also displayed signiﬁcant loss in grip strength but to a
much lesser extent compared to the ipsilateral forelimb (Fig. 8b). Both
forelimbs showed spontaneous recovery of function over time, with
riluzole treated animals showing signiﬁcant recovery of ipsilateral grip
strength as early as 3 days post-injury compared to vehicle treated ani-
mals (p b 0.01). Riluzole-mediated recovery of contralateral forelimb
grip strength occurred much later, at 23 days post-injury, compared to
vehicle treated controls (p b 0.01). Functional recovery of both fore-
limbs persisted at 6 weeks post-injury. Riluzole elicited recovery of
ipsilateral grip strength above the spontaneous recovery seen in
the vehicle-treated control animals, which plateaued by 11 days
after injury.
Using CatWalk gait analysis, we found that, at 2 weeks post-injury,
the swing speed was signiﬁcantly different amongst the treatment
groups with the riluzole treated group having greater swing speed
(p b 0.005) (Fig. 9). This difference persisted at both 4 and 6 weeks
(p b 0.05), however at 6 weeks the difference did not reach signiﬁcance.
The riluzole treated group had swing speeds of 0.43 ± 0.02 mm/ms,
0.55 + 0.05 mm/ms, and 0.5 ± 0. mm/ms, at 2, 4 and 6 weeks respec-
tively. In comparison the vehicle treated group had swing speeds of
0.32 ± 0.02 mm/ms, 0.42 ± 0.02 mm/ms and 0.38 ± 0.06 mm/ms at
2, 4 and 6 weeks, respectively. Similarly, ipsilateral stride length was
different between the riluzole treated and vehicle treated groups at
2 and 4 weeks post-injury (p b 0.001 and p b 0.008). At 6 weeks
post-injury, the difference in stride length between the riluzole
treated group and vehicle treated control did not reach signiﬁcance
(p = 0.197).
Animals that had been subjected to sham injury did not display pref-
erential use of a single paw. In theﬁrst week following injury, animals in
the control group that had been treated with vehicle solution used the
contralateral paw preferentially while exploring the cylinder whereas
the ipsilateral forepaw was held close to the body and the animals
were unable to make placements on the wall (Fig. 10). Number of
paw placements made with both paws simultaneously and/or the use
of ipsilateral forepaw were signiﬁcantly more in the injured animals
treated with riluzole compared to vehicle treated controls (p b 0.05).
In line with these results CatWalk analysis revealed that the forepaw
print width during stance phase was signiﬁcantly increased in the
riluzole treated animals compared to control animals at 2, 4 and
6 weeks post-injury (p b 0.01, p = 0.005 and p = 0.005, respectively).
Speciﬁcally, in the riluzole treated group the forepaw print width was
14.17 ± 0.32 mm, 13.65 ± 0.23 mm and 13.6 ± 0.57 mm at 2, 4 and
6 weeks post-injury. The vehicle treated group had print widths of
12.42 ± 0.51 mm, 9.57 ± 0.78 mm and 10.1 + 0.35 mm at the above
time points. In addition, ipsilateral print lengths of riluzole treated ani-
mals at 2, 4 and 6 weeks were 16.00 + 0.51 mm, 16.53 ± 0.80 mm
and 18.23 ± 1.20 mm respectively. Those of vehicle treated animals
were 12.42 ± 0.31 mm, 13.06 ± 0.42 mm and 14.96 ± 0.45 mm at 2,
4 and 6 weeks respectively. Print length of the ipsilateral forepaw in
control animals was signiﬁcantly lower than those of the treated ani-
mals at 2, 4 and 6weeks (p b 0.005, p b 0.005 and p b 0.05, respectively).
However, the print width and length of the contralateral forepaw were
not signiﬁcantly different between treatment groups. On the ipsilateral
side, the print width was similar at all three time points while thevehicle treated animals showed a signiﬁcant decline in print width at
both 4 and 6 weeks compared to the initial measurement at the
2 weeks post-injury time.
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functional recovery following high cervical hemisection injury
Diaphragmatic EMGwas recorded from a subset of animals under an-
esthesia at 2 weeks post-C2 hemisection to determine the proportion of
animals that showed recovery of ipsilateral hemidiaphragm EMG activity
during eupnea. At twoweeks post-injury, some animals that had been in-
jured showed recovery of ipsilateral diaphragmatic function that was
rhythmic and synchronous with the intact contralateral hemidiaphragm
(Fig. 11A). Two weeks after injury, 2 out of 9 vehicle treated animals
(22.2%) showed recovery of ipsilateral hemidiaphragm EMG activity
(Fig. 11B). Riluzole treatment following cervical injury led to an increase
in the percentage of animals that showed ipsilateral diaphragmatic recov-
ery, with 5 out of the 6 animals (83.3%) showing recovery.
The extent of ipsilateral hemidiaphragm EMG recovery was deter-
mined by calculating the peak inspiratory burst amplitude from raw
EMG tracings in only those that displayed recovered respiratory activity.Fig. 9. Riluzole treatment results in sustained improvement of forelimb and forepaw function a
riluzole treated animals. Riluzole results in increased stride length atweeks 2 and 4 post surgery
and 4 post surgery (p=0.003 for both time points). Riluzole results in greater swing speedmea
in increased stride length at weeks 2 and 4 post surgery (p b 0.001 and p = 0.008).Riluzole treatment signiﬁcantly enhanced the extent of respiratory re-
lated activity on ipsilateral hemidiaphragm (p b 0.05). In vehicle treated
animals that showed recovery, peak inspiratory amplitude was 25.95±
1.24% of the contralateral side of the same animal. In riluzole treated an-
imals the peak inspiratory burst amplitude was 55.07 ± 5.84% of the
contralateral side.
4. Discussion
This study demonstrates that C2 hemisection injury results in de-
creased excitability and most importantly, for the ﬁrst time demon-
strates a signiﬁcant loss of motoneurons within the caudal cervical
spinal cord housing the forelimb and respiratory spinal networks. Fur-
ther, we demonstrate that acute and subacute riluzole administration
upregulates GLUR1 and NR2A subunits of AMPA and NMDA receptors,
and enhances motoneuronal excitability. Most importantly, riluzole
had a signiﬁcant impact inminimizing this loss ofmotoneurons residingfter C2 hemilesion injury. Representative ipsilateral forelimb tracings of gait in control and
(p b 0.001 andp=0.008 respectively). Riluzole results in increasedprint length atweeks 2
sured atweeks 2 and 4 post surgery (p=0.005 and p=0.022). Riluzole treatment results
Fig. 10. The number of forelimb placements (left, right, and both) on the cylinder was
counted and expressed as a percentage of total placements. Percentage of ipsilateral
paw placements was signiﬁcantly higher in the C2 hemisected animals treated with
riluzole compared control animals receiving vehicle solution (2-way ANOVA, p b 0.001
at all time points).
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niﬁcant forelimb and respiratory motor recovery.
Protection of spinal tissue can be a signiﬁcantmediator of functional
recovery following SCI and it has been demonstrated that even a small
amount of preserved tissue can lead to substantial functional recovery
through neuroplasticity of the remaining tissue. Glutamate levels are
signiﬁcantly increased within the spinal cord following SCI (Panter
et al., 1990) and dysregulation of glutamate transmission and over-
activation of glutamate receptors are detrimental to neural tissue at
the site of injury (Xu et al., 2004, 2008). One strategy for minimizing
the secondary injury and preserving tissue in the injured spinal cord
involves minimizing this rapid and immediate decrease in intraspinal
glutamate levels. Indeed, our laboratory and others have previously
demonstrated that the antiglutamatergic effects of riluzole can provide
neuroprotection at and around the site of initial injury (Wu et al., 2013,
2014; Schwartz and Fehlings, 2001, 2002; Karadimas et al., 2013;
Mu et al., 2000; Wilson et al., 2013; Mazzone and Nistri, 2011;
Lang-Lazdunski et al., 2000; McAdoo et al., 2005; Moon et al., 2014;
Stutzmann et al., 1996). Although riluzole promotes modest motor
recovery in preclinical models of SCI, the exact mechanisms of action
remain unclear limiting our ability to fully harness its therapeutic
potential for SCI. Here, we have used a C2 hemisection injury
model in order to explore the capacity of riluzole to promote sustained
neuroplasticity.
Organization and functionality of the spinal cord are determined, to
a large extent, by the diversity of neuronal populations and their
connectivity. Following acute SCI, main axonal pathways transporting
glutamatergic input onto the ventral horn motoneurons are disrupted
(Shapiro, 1997). The majority of research to date, utilizing the
established C2 hemisection model of incomplete SCI, has focused on
promoting plasticity within the spared spinal circuitries to bring about
functional recovery (Mantilla et al., 2013; Baker-Herman et al., 2004;
Golder et al., 2003; Ling et al., 2001). Speciﬁcally, acute and chronic in-
terventions using pharmacological agents and intermittent hypoxia
training have been used to activate latent axonal pathways that cross
the spinal cord below the injury to promote functional plasticity
(Baker-Herman et al., 2004; Li et al., 2014; Nantwi and Goshgarian,
2001; Dale-Nagle et al., 2010; MacFarlane et al., 2011). However, little
attention has been paid to the survival of the motoneuronal elements
that comprise these circuitries located caudal to the C2 hemisection
and subsequently to the development of therapies targeted at limiting
this loss (Alilain and Goshgarian, 2007, 2008; Goshgarian, 2003;
Zimmer and Goshgarian, 2005; Fuller et al., 2009; Agrawal and
Fehlings, 1997; Baker-Herman et al., 2010). Here, we show that the C2
hemisection injury results in decreased descending input onto moto-
neurons leading to signiﬁcant loss of motoneurons located distal to
the initial injury. For the ﬁrst time, we provide evidence not only sug-
gesting motoneuron loss caudal to the C2 hemisection injury but also
supporting riluzole treatment as a potential means to limit this loss.
Various ionotropic glutamate receptor subunits are strongly impli-
cated in the induction and maintenance of neuroplasticity within the
central nervous system. Of the three types of ionotropic glutamate
receptors, NMDA and AMPA receptors have been shown to alter in re-
sponse to neuronal activity. The type of glutamate subunits that com-
bine to form the glutamate receptor inﬂuences the ﬁring property of
motoneurons (Myers et al., 1999; Dingledine et al., 1999). AMPA recep-
tor composition can have a signiﬁcant impact on motoneuronal excit-
ability while NMDA receptors function as coincidence detectors to
strengthenweak synaptic connections (Evans et al., 2012). In particular,
increased expression of the GLUR1 subunit of the AMPA receptor and
the NR2A subunit of the NMDA receptor have been strongly linked to
synaptic strengthening associated with LTP, the cellular substrate of
learning and memory, as well as respiratory plasticity (Alilain and
Goshgarian, 2007, 2008; Lee et al., 2000; Mitsushima et al., 2011; Shao
et al., 2003). Loss of descending activity following SCI has been linked
to changes in the expression of NMDA and AMPA receptor subunits(Mantilla et al., 2012; Alilain and Goshgarian, 2008; Grossman et al.,
1999, 2000; Anderson et al., 2005). In the setting of SCI, modulation of
both NMDA and AMPA receptors has been previously shown tomediate
neuroplasticitywithin the cervical spinal cord following C2 hemisection
injury (Mantilla et al., 2012; Alilain and Goshgarian, 2008). Indeed, this
is supported by our ﬁndings of an increase in NR2A andGLUR1 subunits
in the cervical ventral horn and the increase in motoneuronal excitabil-
ity in the riluzole treated group.
Based on the literature (Sim et al., 2013; Bacci et al., 2001; Gomperts
et al., 1998, 2000; Malenka, 2003; Nicoll and Malenka, 1999; Grooms
et al., 2006) riluzole-mediated increase in cervical motoneuron excit-
ability could promote synaptic strengthening through modiﬁcation of
pre- and postsynaptic neuronal properties. Indeed, we found a concom-
itant increase in the presynaptic input onto the motoneurons of the
riluzole treated group as measured by the increased synaptophysin ex-
pression on the ChAT positive cells in the anterior horn of gray matter.
Taken together, these ﬁndings suggest that the ability of riluzole to
modulate glutamate receptor expression has the potential to inﬂuence
pre-and post-synaptic membranes to enhance synaptic strength and
to amplify excitability and functional plasticity of preserved motoneu-
ronswithin distal spinalmotoneurons. This activity-dependent increase
in the presynaptic input could underlie the survival, connectivity and
function of the motoneurons and provide novel mechanistic insights
into the effects of riluzole following injury in the CNS.
SCI patients place high priority on regaining arm and hand function
(Alexander et al., 2009) aswell as on acquiring ventilator independence
for enhanced quality of life, making these functional improvements of
paramount importance in SCI research (Anderson et al., 2005). Pulmo-
nary complications such as infection, atelectasis and ventilator depen-
dence due to hypoventilation are the leading causes of death amongst
SCI patients (Kelley et al., 2003). Our neurobehavioral results verify pre-
vious ﬁndings that riluzole treatment leads to neurobehavioral im-
provements (Wu et al., 2013, 2014; Schwartz and Fehlings, 2001;
Anon., 2003; Baptiste and Fehlings, 2006) and extends the ﬁndings re-
lating to the beneﬁts of riluzole by providing evidence for riluzole's abil-
ity to bring forth early and sustained forelimb functional recovery and
restore respiratory related diaphragmatic function. In this study we
have used diaphragmatic EMG recordings in spontaneously breathing
animals to assess respiratory recovery. We were able to maintain com-
parable conditions in all groups. Further, we did not ﬁnd a difference in
respiratory frequency between the riluzole and vehicle groups indicat-
ing a similar respiratory drive in both groups. This riluzole-mediated
early forelimb functional recovery following high cervical SCI has
never been demonstrated previously and this study provides evidence
Fig. 11. Diaphragmatic EMG assessment. (A) Representative raw left hemidiaphragmatic EMG and integrated EMG activity taken from uninjured, left C2 hemisected animal treated with
riluzole or vehicle two weeks post-injury. (B) Four out of the 5 riluzole treated animals had recovery of respiratory related diaphragmatic activity on the lesioned side. At two weeks, a
higher percentage of animals that received riluzole had recovery of hemidiaphragmatic function on the lesioned side. (C) The riluzole treated animals had a higher peak inspiratory
burst amplitude compared to the vehicle treated group (t-test, p b 0.05).
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anatomical ﬁndings, our ﬁndings of early recovery of ipsilateral gripping
ability at three days post-injury further suggest that neuroplasticity rather
than regeneration is the underlying mechanism of recovery. Although
there is limited existing evidence for the potential role of riluzole in func-
tional plasticity, the ﬁndings of this study suggest a glutamate receptor
antagonism-mediated homeostatic plasticity similar to what has been
reportedwith other glutamatemodulators in the respiratory and locomo-
tor networks (Mantilla et al., 2012; Alilain and Goshgarian, 2007, 2008).
Unlike the other modulators, the proven safely record of riluzole in the
clinical setting makes it an attractive option.
The ﬁndings presented here indicate that the acute administration
of riluzole for a week post-injury is a potential approach to promote
neuroprotection of caudal neural circuitries responsible for forelimb
and respiratory function. Although therapeutic beneﬁts of riluzolehave been demonstrated in other models of SCI, the use of the C2
hemisectionmodel allowed us to demonstrate its potential effect on syn-
aptic input and number ofmotoneurons located caudal to the site of inju-
ry. In fact, this study demonstrates the effectiveness of a drug that can
improve two of themost devastating consequences of SCI, impaired fore-
limb and respiratory function. As this drug is currently in Phase III trials,
this work is expected to have an impact for the treatment of SCI.
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